MAPT and Alzheimer disease: Using a semi-targeted mass spectrometry approach we were able to detect peptides corresponding to proteolytic cleavage of tau by GzmA in AD and PSP brains, suggesting that proteolytic cleavage of tau by GzmA may be relevant to disease pathogenesis.